Sana Biotechnology, Inc. (SANA) Financials
SANA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 565.3 million | 277.8 million |
2023-09-30 | 631.4 million | 265.6 million |
2023-06-30 | 707.1 million | 352.1 million |
2023-03-31 | 746.9 million | 318.7 million |
SANA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -66.0 million | 7.9 million |
2023-09-30 | -65.8 million | 9.0 million |
2023-06-30 | -60.4 million | 9.8 million |
2023-03-31 | -81.4 million | 8.8 million |
SANA Net Income
No data available :(
SANA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 209.0 million | - | 104.1 million |
2023-09-30 | 268.6 million | - | 96.9 million |
2023-06-30 | 325.9 million | - | 113.1 million |
2023-03-31 | 355.1 million | - | 114.5 million |
SANA Shares Outstanding
SANA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 14.0 million | 48.5 million | 20.8 million | - |
2023-09-30 | 2.2 million | 17.0 million | 19.2 million | - |
2023-06-30 | 1.6 million | 99.7 million | 16.6 million | - |
2023-03-31 | 2.2 million | 67.3 million | 16.8 million | - |
SANA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 7.5 million |
2023-09-30 | - | 4.5 million |
2023-06-30 | - | 7.8 million |
2023-03-31 | - | 7.7 million |
SANA
Price: $9.63
52 week price:
Earnings Per Share: -1.46 USD
P/E Ratio: -4.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.2 million
Market Capitalization: 2.0 billion